Robinhood’s Limited Crypto Products & Declining Trading Volume Flagged As Concerns, This Analyst Initiates With A Hold
Needham analyst John Todaro initiated coverage on Robinhood Markets Inc (NASDAQ: HOOD)
Benzinga’s Top Ratings Upgrades, Downgrades For October 11, 2023
Upgrades For Coherent Corp (NYSE:COHR), B. Riley Securities upgraded the previous rating of Neutral to Buy. In the…
RayzeBio Is A New Contender in Radiopharmaceutical Arena, Will Attract Prominent Entities: JP Morgan
JP Morgan has initiated coverage on RayzeBio Inc (NASDAQ: RYZB), representing a pure-play opportunity in the radiopharmaceutical space.
MannKind Analyst Turns Bullish, Says ‘Don’t Call It Comeback’
Shares of MannKind Corp (NASDAQ: MNKD) were climbing in early trading on Tuesday.
Benzinga’s Top Ratings Upgrades, Downgrades For October 10, 2023
Upgrades According to RBC Capital, the prior rating for Montrose Environmental Group Inc (NYSE:MEG) was changed from Sector…
Why Neumora Therapeutics Analysts Are Bullish About Major Depressive Disorder Drug
Shares of Neumora Therapeutics Inc (NASDAQ: NMRA) were trading lower on Tuesday, a month after the company announced its IPO on the NASDAQ exchange.
Analyst Bullish On Calidi Biotherapeutics, Newly Listed Cancer Treatment Player
Baird initiates coverage on Calidi Biotherapeutics Inc (NYSE: CLDI), which uses allogeneic stem cells to deliver oncolytic viruses to tumors for cancer treatment.
Preclinical-Phase Firm Prime Medicine’s Gene Editing Platform Has Potential: Analyst
BMO Capital Markets has initiated coverage on Prime Medicine Inc (NASDAQ: PRME), a preclinical-stage company focused on developing therapies based on prime editing.
ARM’s Growth Trajectory: Analysts Bullish on Expansion in AI, Data Centers, Edge Computing And Rising Royalties
Goldman Sachs analyst Toshiya Hari initiated coverage on ARM Holdings Plc (NASDAQ: ARM) with a Buy rating and a
Benzinga’s Top Ratings Upgrades, Downgrades For October 9, 2023
Upgrades Scotiabank upgraded the previous rating for Mirati Therapeutics Inc (NASDAQ:MRTX) from Sector Underperform to Sector Perform. For…